No Benefit of Colchicine After Stroke, TIA: CHANCE-3

The anti-inflammatory agent, started within 24 hours of acute ischemic stroke or TIA, did not reduce subsequent stroke or other vascular events at 90 days in the CHANCE-3 trial.

Related Keywords

China ,Toronto ,Ontario ,Canada ,Chinese ,Yongjun Wang ,Ashkan Shoamanesh ,National Institutes Of Health Stroke Scale ,Mcmaster University ,World Stroke Congress ,Capital Medical University ,Beijing Tiantan Hospital ,National Institutes ,Health Stroke Scale ,Modified Rankin Scale ,Medscape Cardiology ,Stroke ,Erebrovascular Accident ,Va Cerebrovascular Accident ,Thromboembolism ,Ischemic Stroke ,Anti Inflammatory Agents ,Atherosclerotic Heart Disease ,Therosclerotic Cardiovascular Disease ,Oronary Heart Disease ,Schemic Heart Disease ,Transient Ischemic Attack ,Cia ,Cv ,Ardiovascular ,Atherosclerosis ,Cerebrovascular Disease ,